Skip to content
DraconiticResearch
Search Sources API
211,646 studies31 sourcesUpdated 31 min ago

Oncology

5,331 studies510 in 7 days2,567 in 30 days

Filters
Type
Date
Clear

Latest

5,331 studies

  1. Predicting Neoantigen Immunogenicity from In Vivo Immune Editing
    T. J. Sears, K.-h. Lee, M. Munoz Perez +7
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  2. Neoantigen-reactive CD8+ T cell engagement marks exceptional survivors of pancreatic cancer
    M. Hilmi, J. D. Schoenfeld, W. McKerrow +39
    bioRxivPreprintCC BYFull textOncologybioRxiv
  3. Spatial/molecular heterogeneity and treatment response in HER2+ early breast cancer: Translational analyses from the DAPHNe trial
    E. Chen, I. Schlam, K. Shimada +25
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  4. Activation of a STAT3/LATS1 Signaling Axis by Folate Receptor α Enables Breast Cancer Cells to Resist Physiological Ferroptotic Stress
    P. P. Ambegaokar, H. L. Goel, E. R. Karner +3
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  5. Carcinogen-induced preinvasive human squamous lung cancer is characterised by a novel atypical basal cell state and presents opportunities for chemoprevention
    W. Guo, H. Giles, A. Chernaik +13
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  6. A Measurable Systemic Immune Phenotype Links Circulating Myeloid Dysfunction to Tumour Spatial Organization in Gastroesophageal Adenocarcinoma
    I. Dhoparee-Doomah, Y. Li, M. Al Dow +16
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  7. p53 knockout drives stage-specific long non-coding RNA reprogramming during human neural differentiation and glioma organoid tumorigenesis.
    F. Stasi, A. R. Manzari, V. Siciliano +4
    bioRxivPreprintCC BYFull textOncologybioRxiv
  8. TALAVE in Breast Cancer: BRCA1/2 Mutation-Dependent Immune Remodeling after PARP Inhibition with Limited Checkpoint Engagement
    F. Lynce, K. Shimada, C. Isaacs +18
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  9. ERK5 inhibition triggers CDK6 proteasomal degradation and enhances palbociclib efficacy in cancer cells
    C. Faundez Vidiella, Y. Sfragano, I. Tusa +4
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  10. Methylation-Based ctDNA for Post-Treatment Surveillance of Non-Viral Head and Neck Cancer
    D. Tomer, P. Brodin, N. Malik +10
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  11. Expanding Synthetic Lethality in DNA Damage Response-Defective Cancers Through Stress Phenotype-Guided Kinase Targeting
    Mirco Masi, Giulia Varignani, Andrea Cavalli +1
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0OncologyCrossref
  12. 8th International consensus guidelines for the management of advanced breast cancer (ABC8 guidelines)
    Fatima Cardoso, Joana Mourato Ribeiro, Eva Schumacher-Wulf +50
    The Breast : Official Journal of the European Society of MastologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMCEurope PMC
  13. LNK expression, subcellular localization and survival associations in breast, cervical and colorectal cancer
    Jessica C Mantilla-Ollarves, Alejandro Sánchez-Carballido, Alejandro Ordaz-Ramos +5
    Biomolecules and BiomedicinePeer-reviewedCC BY 4.0Full textOncologyHAL
  14. Blood test trend versus single threshold abnormality to discriminate cancer from non-cancer in patients with unexpected weight loss: A retrospective cohort study
    Brian D. Nicholson, Clare R. Bankhead, Sufen Zhu +5
    PLOS MedicinePeer-reviewedCC BY 4.0Full textOncologyPhysiologyPLOS
  15. Safety of eribulin: A real-world study based on a pharmacovigilance database
    Yao Zhou, Jie Gong, Lele Shen +5
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPhysiologyPLOS
  16. A cross-sectional study on illness perception and resiliency among cancer patients, in Bhaktapur cancer hospital
    Pooja Panth, Abaru Panta, Kabita Raj Cadel +1
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  17. The COP9 signalosome subunit CSN1 regulates glioblastoma stem cell growth
    Samir Assaf, Kyle Heemskerk, Xiaoguang Hao +2
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  18. A segmentation-guided CNN–Vision transformer feature fusion framework for multi-class breast ultrasound image classification
    Meiru Wu, Jian Wang
    PLOS OnePeer-reviewedCC BY 4.0Full textMedical imaging & radiologyOncologyPLOS
  19. Computational screening of oncogenic genetic variations in tumor suppressor proteins driving gastric cancer pathogenesis
    Faria Ferdouse Mim, Taslima Akter Sumiya, Roksana Khanam +6
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  20. “I had your number on speed dial:” A qualitative study of patient experiences of dietetics care and managing nutrition during curative treatment of upper gastrointestinal cancer
    Irene Deftereos, Justin Yeung, Nicole Kiss +4
    PLOS OnePeer-reviewedCC BY 4.0Full textNutritionOncologyPhysiologyPLOS
  21. Tickets for p53 journey among organelles
    Ioana Ferecatu
    Frontiers in BiosciencePeer-reviewedLicence not statedFull text18 citedOncologyHAL
  22. Concomitant mutation status of ALK-rearranged non-small cell lung cancers and its prognostic impact on patients treated with crizotinib
    Jingjing Li, Bin Zhang, Yu Zhang +12
    Translational Lung Cancer ResearchPeer-reviewedCC BY-NC-ND 4.0Full text19 citedOncologyHAL
  23. An integrated Phase II/III randomized study comparing durvalumab and tremelimumab ± Hepatic ArteriaL infusion chemotherapy with GEMOX in hepatocellular Carcinoma with high tumor burdEn – ALICE (PRODIGE89 – UCGI44 – ALICE)
    Octave Letissier, Xavier Adhoute, Boris Campillo-Gimenez +21
    Digestive and Liver DiseasePeer-reviewedCC BY-NC-NDFull textOncologyHAL
  24. Diagnostic pitfalls and unmet needs in neuroendocrine neoplasms: The added value of collegial expert pathology review through the national TENpath network
    Matthieu Tihy, Jean-Yves Scoazec, Serge Guyétant +30
    European Journal of CancerPeer-reviewedCC BY 4.0Full textOncologyHAL
  25. Immunometabolic interactions in gynecologic cancers: Mechanisms, biomarkers, and therapeutic implications
    Agapiti H. Chuwa, David H. Mvunta
    The Journal of International Medical ResearchPeer-reviewedCC BY-NC 4.0Full textOncologyPMC